Coated Tube HCG Immunoassay HCG
510(k) K841023
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK841023 | Date1 May 1984 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- JHI
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1155
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 22 Sep 2026
This device is a coated tube HCG immunoassay HCG, used for the visual detection of human chorionic gonadotropin (hCG) in urine specimens. It is classified as a Class II medical device under the Clinical Chemistry specialty and is intended for prescription use.
The device received traditional 510(k) clearance (K841023) from the FDA on May 1, 1984, and is substantially equivalent to a legally marketed predicate device. It is manufactured by Ventrex Laboratories, Inc., and is supplied as a non-sterile, single-use in vitro diagnostic test system for use in clinical laboratory settings.
Other devices from Ventrex Laboratories, Inc.
Questions
AI-generated answers, 22 Sep 2026
What is the COATED TUBE HCG IMMUNOASSAY HCG used for?
This device is used for the visual detection of human chorionic gonadotropin (hCG) in urine specimens. It is an in vitro diagnostic test system intended for prescription use in clinical laboratory settings to aid in pregnancy testing.
How is the COATED TUBE HCG IMMUNOASSAY HCG supplied and is it sterile or reusable?
The device is supplied as a non-sterile, single-use in vitro diagnostic test system. It is designed for one-time use only and should not be reused, as reuse could compromise test accuracy and increase contamination risk.
What regulatory pathway was used for the COATED TUBE HCG IMMUNOASSAY HCG and when was it cleared?
The device received traditional 510(k) clearance (K841023) from the FDA on May 1, 1984, and is substantially equivalent to a legally marketed predicate device. This clearance pathway confirms its safety and effectiveness for the intended use.